2012
DOI: 10.3233/jad-2011-111118 View full text |Buy / Rent full text
|
|

Abstract: This work describes a novel mechanism of neuroprotection by simvastatin: the modulation of seladin-1, an enzyme involved in Alzheimer's disease. Genomic and proteomic studies in human neuronal cells showed seladin-1 production to be increased in a dose- and time-dependent manner by simvastatin. This was confirmed in mice by immunohistochemical and qRT-PCR studies.

Help me understand this report

Search citation statements

Order By: Relevance
0
0
0
0
0
0
11
0

Publication Types

Select...

Relationship

0
0

Authors

Journals